President of the American Academy of Dermatology.

American Academy of Dermatology disagrees with eczema medication action used by FDA The American Academy of Dermatology has issued a statement in response to the U here .S. These topical medications successfully reduce the inflammation and various other symptoms associated with the skin condition eczema. Cockerell, M.D., president of the American Academy of Dermatology. These are valuable medicines, and if used correctly, they allow millions of our patients with eczema to live regular lives. The dermatologists, patients, immunologists and pharmacists taking part in the conference reviewed the existing literature and protection data for these medications.